SCHEMBL29904245

SCHEMBL29904245

COc1ccc(-c2cnc(Cl)cc2F)c(F)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 3/20 0.46
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
USP7 Q93009 1/20 0.43
PRKAB2 O43741 2/20 0.42
PRKAG1 P54619 2/20 0.42
PRKAA2 P54646 2/20 0.42
PRKAA1 Q13131 2/20 0.42
PRKAG3 Q9UGI9 2/20 0.42
PRKAG2 Q9UGJ0 2/20 0.42
PRKAB1 Q9Y478 2/20 0.42
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CYP17A1 P05093 2/20 0.41
CYP11B1 P15538 2/20 0.41
CYP11B2 P19099 2/20 0.41
GRM2 Q14416 1/20 0.40
CLK1 P49759 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27415952 1.00 AMY1A (0.46) AMY1APTGS1PTGS2USP7PRKAB2
SCHEMBL27415921 0.84 RPS6KA3 (0.46) PTGS2USP7NPC1RAB9AMEN1
SCHEMBL10340365 0.80 AMY1A (0.50) AMY1APRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL17436330 0.77 CLK1 (0.47) AMY1APTGS1PTGS2USP7PRKAB2
SCHEMBL12987241 0.75 AMY1A (0.50) AMY1APTGS1PTGS2NPC1RAB9A
SCHEMBL14637411 0.74 AMY1A (0.43) AMY1APTGS1PTGS2USP7PRKAB2
SCHEMBL19387237 0.72 AMY1A (0.46) AMY1APTGS1PTGS2USP7PRKAB2
SCHEMBL15832088 0.72 KCNQ3 (0.45) NPC1RAB9A
SCHEMBL8430167 0.72 KDM1A (0.55) AMY1ANPC1RAB9ACYP17A1CYP11B1
SCHEMBL22537008 0.72 NPC1 (0.55) AMY1ANPC1RAB9AGRM2ERN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022212818-A1 1,2,4-TRIAZOLO[4,3-A]PYRIDINE DERIVATIVES AS NEGATIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 VANDERBILT UNIVERSITY (US) 2022-10-06 WO disclosed